Novolog Investor Relations Investors Lobby Company Profile Company Presentation Immediate Reports Financial Reports General Meetings From The Press Stock Chart FAQ Mail Alert Contact IR Stock Quote NVLG 159.3 2.5 (1.59%) TASE D/Low: 158.2 D/High: 160 Last Update: 12/12/2019 at 17:24 Presentations Investors Presentation March 2019 Financial Reports 3rd Quarter 2019 2nd Quarter 2019 1st Quarter 2019 General Meetings Calling of Special meeting for Novmber 14, 2019 28/10/2019 Calling of Annual meeting for July 02, 2019 27/05/2019 Immediate Reports Results of general meeting 14/11/2019 Signed and completed addition to Medicaip agreement, exercise option to purchase minority holding (30%) in Medicaip 12/11/2019 Calling of special meeting for 14.11.19 28/10/2019 Read more From The Press The Marker: Novologist has invested NIS 31.5 million – and has taken full control of Medikip 12/11/2019 Read more Mail Alert Subscribe to Receive Notifications by Email First Name Last Name Email Send
Signed and completed addition to Medicaip agreement, exercise option to purchase minority holding (30%) in Medicaip 12/11/2019
The Marker: Novologist has invested NIS 31.5 million – and has taken full control of Medikip 12/11/2019
